GRID/CPCA: A New Computational Tool To Design Selective Ligands-Reference-Cited by-同舟云学术

GRID/CPCA: A New Computational Tool To Design Selective Ligands

Published:2000-07-25 Issue:16 Volume:43 Page:3033-3044
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kastenholz Mika A.¹,Pastor Manuel¹,Cruciani Gabriele¹,Haaksma Eric E. J.¹,Fox Thomas¹

Affiliation:

1. Department of Chemical Research/Structural Research, Boehringer Ingelheim Pharma KG, 88397 Biberach/Riss, Germany, and Laboratory for Chemometrics, University of Perugia, Via Elce di Sotto 10, 06123 Perugia, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm000934y

Reference58 articles.

1. A search for specificity in DNA-drug interactions

2. A Novel Strategy for Improving Ligand Selectivity in Receptor-Based Drug Design

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning in structural bioinformatics: current applications and future perspectives;Briefings in Bioinformatics;2024-03-27

2. Screening of phytochemicals from Clerodendrum inerme (L.) Gaertn as potential anti-breast cancer compounds targeting EGFR: an in-silico approach;Journal of Biomolecular Structure and Dynamics;2023-12-23

3. A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans †;Molecules;2023-04-12

4. Hydrothermal Synthesis, crystal structure, DFT studies, and molecular docking of Zn-BTC MOF as potential antiprotozoal agents;Journal of Molecular Structure;2023-04

5. Insights into In Silico Methods to Explore Plant Bioactive Substances in Combating SARS-CoV-2;Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products;2023